Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB9801-100 - Provider product page
- Provider
- R&D Systems
- Product name
- Mouse TIMP-1 Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from hybridoma culture supernatant. Detects mouse TIMP-1 in direct ELISAs and Western blots. Shows 100% cross-reactivity with recombinant rat TIMP-1 and 20% cross-reactivity with recombinant human TIMP-1.
- Reactivity
- Mouse
- Host
- Rat
- Conjugate
- Unconjugated
- Antigen sequence
P12032
- Isotype
- IgG
- Antibody clone number
- 151624
- Vial size
- 100 ug
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction.
The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis.
Lu D, Liao Y, Zhu SH, Chen QC, Xie DM, Liao JJ, Feng X, Jiang MH, He W
Stem cell research & therapy 2019 Apr 27;10(1):127
Stem cell research & therapy 2019 Apr 27;10(1):127
The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
Adrian-Segarra JM, Sreenivasan K, Gajawada P, Lörchner H, Braun T, Pöling J
The Journal of biological chemistry 2018 Dec 28;293(52):20181-20199
The Journal of biological chemistry 2018 Dec 28;293(52):20181-20199
TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis.
Davidsen ML, Würtz SØ, Rømer MU, Sørensen NM, Johansen SK, Christensen IJ, Larsen JK, Offenberg H, Brünner N, Lademann U
British journal of cancer 2006 Oct 23;95(8):1114-20
British journal of cancer 2006 Oct 23;95(8):1114-20
No comments: Submit comment
No validations: Submit validation data